Cumberland Pharmaceuticals (CPIX) Cash from Discontinued Operations (2019 - 2021)

Cumberland Pharmaceuticals (CPIX) has 3 years of Cash from Discontinued Operations data on file, last reported at 503318.0 in Q4 2021.

• For the quarter ending Q4 2021, Cash from Discontinued Operations fell 62.78% year-over-year to 503318.0; the trailing twelve-month figure through Sep 2022 stood at 503318.0 (down 82.3% YoY), and the FY2021 full-year result was 1994322.0, down 43.31% from the prior year.
• Cash from Discontinued Operations rose to 503318.0 in Q4 2021, from 496787.0 in the prior quarter.
• In the past five years, Cash from Discontinued Operations ranged from a high of 3027800.0 in Q4 2019 to a low of 38567.0 in Q2 2020.
• A 3-year average of 918680.0 and a median of 648983.5 in 2020 frame the typical range for Cash from Discontinued Operations.
• Across the five-year window, Cash from Discontinued Operations sank 97.11% in 2020 and surged 1193.35% in 2021, its largest moves.
• Tracing CPIX's Cash from Discontinued Operations over 3 years: stood at 3027800.0 in 2019, then slumped by 55.34% to 1352156.0 in 2020, then slumped by 62.78% to 503318.0 in 2021.
• Business Quant data shows CPIX's Cash from Discontinued Operations at 503318.0 in Q4 2021, 496787.0 in Q3 2021, and 498807.0 in Q2 2021.